-
15924-10A selective small molecule inhibitor of PKD (IC<sub>50</sub>s = 182, 280, 227 nM for PKD1, 2, and 3, respectively) 25 µM has been shown to inhibit prostate cancer cell proliferation, cell migration, and invasion.
-
15924-25A selective small molecule inhibitor of PKD (IC<sub>50</sub>s = 182, 280, 227 nM for PKD1, 2, and 3, respectively) 25 µM has been shown to inhibit prostate cancer cell proliferation, cell migration, and invasion.
-
15924-5A selective small molecule inhibitor of PKD (IC<sub>50</sub>s = 182, 280, 227 nM for PKD1, 2, and 3, respectively) 25 µM has been shown to inhibit prostate cancer cell proliferation, cell migration, and invasion.
-
13113-100An acyclic nucleoside phosphonate that is active against many different viruses including herpesvirus CMV selectively inhibits CMV replication and CMV DNA synthesis (IC<sub>50</sub> = 0.1 &muM).
-
13113-25An acyclic nucleoside phosphonate that is active against many different viruses including herpesvirus CMV selectively inhibits CMV replication and CMV DNA synthesis (IC<sub>50</sub> = 0.1 &muM).
-
13113-50An acyclic nucleoside phosphonate that is active against many different viruses including herpesvirus CMV selectively inhibits CMV replication and CMV DNA synthesis (IC<sub>50</sub> = 0.1 &muM).
-
71730-1An antidiabetic drug and selective PPAR&gamma agonist (EC<sub>50</sub> = 3.0 µM) active in vivo as an anti-hyperglycemic agent the ob/ob mouse model.
-
71730-10An antidiabetic drug and selective PPAR&gamma agonist (EC<sub>50</sub> = 3.0 µM) active in vivo as an anti-hyperglycemic agent the ob/ob mouse model.
-
71730-5An antidiabetic drug and selective PPAR&gamma agonist (EC<sub>50</sub> = 3.0 µM) active in vivo as an anti-hyperglycemic agent the ob/ob mouse model.
-
71730-50An antidiabetic drug and selective PPAR&gamma agonist (EC<sub>50</sub> = 3.0 µM) active in vivo as an anti-hyperglycemic agent the ob/ob mouse model.
-
14455-10A selective inhibitor of PDE3A and PDE3B (IC<sub>50</sub>s = 27 and 50 nM, respectively) inhibits thrombin-induced platelet aggregation (IC<sub>50</sub> = 1.1 &muM).
-
14455-25A selective inhibitor of PDE3A and PDE3B (IC<sub>50</sub>s = 27 and 50 nM, respectively) inhibits thrombin-induced platelet aggregation (IC<sub>50</sub> = 1.1 &muM).